Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James McInerney

Neurological Surgery Hershey, PA Medical Doctor

NPI 1528010048 CMS profile 114508

500 University Dr, # McH110, Hershey, PA 17033

Open in the dashboard

General payments

$41,089

624 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$238,262 paid to institutions, not to them · program years 2019–2024

Through program year 2025, James McInerney of Hershey, PA is reported in the CMS Open Payments database as having received $41,089 across 624 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $238,262 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 84th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,372 83
2024 General $14,121 113
2023 General $7,902 95
2022 General $5,124 104
2021 General $6,725 76
2020 General $2,336 78
2019 General $3,509 75

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James McInerney
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to James McInerney were reported at $1,372. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year James McInerney Neurological Surgery median Middle half National median
2019 $3,509 $582 $138–$3,006 $163
2020 $2,336 $294 $76–$2,174 $114
2021 $6,725 $387 $105–$2,432 $132
2022 $5,124 $542 $139–$2,989 $149
2023 $7,902 $534 $145–$2,697 $160
2024 $14,121 $574 $155–$3,046 $164
2025 $1,372 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $32,043 460 payments
  2. Medtronic USA, Inc. $5,220 145 payments
  3. Elekta K.K. $1,500 1 payment
  4. InSightec,Inc $906 6 payments
  5. Zap Surgical Systems, Inc. $710 3 payments
  6. Elekta, Inc. $275 3 payments
  7. Nevro Corp. $145 1 payment
  8. Boston Scientific Corporation $123 1 payment
  9. Abbott Laboratories $113 2 payments
  10. Brainlab, Inc. $55 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $20,200 7 payments
  2. Food and Beverage $10,731 595 payments
  3. Consulting Fee $6,182 5 payments
  4. Travel and Lodging $3,976 17 payments
Products named General payments · program years 2019–2025
  1. PERCEPT PC BRAINSENSE $19,658 238 payments
  2. Percept $5,334 6 payments
  3. ACTIVA $5,094 143 payments
  4. SenSight $2,528 164 payments
  5. INTELLIS ADAPTIVESTIM $2,500 1 payment
  6. EXABLATE $906 6 payments
  7. ZAP-X RADIOSURGERY SYSTEM $500 1 payment
  8. ZAP-X TREATMENT DELIVERY SOFTWARE $500 1 payment
  9. ZAP-X MV IMAGER $500 1 payment
  10. ZAP-X TREATMENT PLANNING SOFTWARE $500 1 payment
  11. Other $2,001 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

84

Median for Neurosurgery: 83

Drug cost

$1,201

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciprofloxacin Hcl Generic 32 $458
Cephalexin Generic 29 $387
Carbamazepine Generic 11 $247
Gabapentin Generic 12 $109

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$123,294

Medicare's payments for the services billed

Medicare patients

176

Average age 73

Services billed

371

77 women, 99 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 54%
Depression 39%
Alzheimer's or dementia 39%
Diabetes 31%
Chronic kidney disease 24%
Ischemic heart disease 23%
Atrial fibrillation 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

624 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record